Progression of geographic atrophy and genotype in age-related macular degeneration.

[1]  T. Becker,et al.  CFH, C3 and ARMS2 Are Significant Risk Loci for Susceptibility but Not for Disease Progression of Geographic Atrophy Due to AMD , 2009, PloS one.

[2]  Frederick L Ferris,et al.  Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. , 2009, Archives of ophthalmology.

[3]  K. Stefánsson,et al.  Geographic atrophy in age-related macular degeneration and TLR3. , 2009, The New England journal of medicine.

[4]  Ronald Klein,et al.  The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study. , 2008, American journal of ophthalmology.

[5]  F. Jónasson,et al.  Prevalence and causes of visual impairment and blindness in Icelanders aged 50 years and older: the Reykjavik Eye Study , 2008, Acta ophthalmologica.

[6]  G. Parmigiani,et al.  Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. , 2008, The New England journal of medicine.

[7]  J. Hoh,et al.  Joint effects of polymorphisms in the HTRA1, LOC387715/ARMS2, and CFH genes on AMD in a Caucasian population , 2008, Molecular vision.

[8]  S. Fisher,et al.  Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA , 2008, Nature Genetics.

[9]  M. Dean,et al.  Bringing age-related macular degeneration into focus , 2008, Nature Genetics.

[10]  Katherine M. James,et al.  Toll-like receptor polymorphisms and age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.

[11]  T. Wong,et al.  Familial aggregation of age-related macular degeneration in the Utah population , 2008, Vision Research.

[12]  Gonçalo R. Abecasis,et al.  A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration , 2007, Proceedings of the National Academy of Sciences.

[13]  I. Deary,et al.  Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.

[14]  G. Ying,et al.  Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial. , 2007, Ophthalmology.

[15]  P. Bernstein,et al.  HTRA1 Variant Confers Similar Risks to Geographic Atrophy and Neovascular Age-related Macular Degeneration , 2007, Cell cycle.

[16]  B. Rosner,et al.  Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. , 2007, JAMA.

[17]  Jens Dreyhaupt,et al.  Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. , 2007, American journal of ophthalmology.

[18]  J. Ott,et al.  The LOC387715 Gene, Smoking, Body Mass Index, Environmental Associations with Advanced Age-Related Macular Degeneration , 2007, Human Heredity.

[19]  Gerald Liew,et al.  Ranibizumab for neovascular age-related macular degeneration. , 2007, The New England journal of medicine.

[20]  Chi Pui Pang,et al.  HTRA1 promoter polymorphism in wet age-related macular degeneration. , 2007, Science.

[21]  N. Camp,et al.  A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration , 2006, Science.

[22]  J. Haines,et al.  Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. , 2006, American journal of human genetics.

[23]  Richard Wormald,et al.  Leading causes of certification for blindness and partial sight in England & Wales , 2006, BMC public health.

[24]  R. T. Smith,et al.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.

[25]  Ronald Klein,et al.  A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. , 2005, Archives of ophthalmology.

[26]  S. Fisher,et al.  Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk , 2005 .

[27]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[29]  A. Edwards,et al.  Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.

[30]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[31]  A. Hofman,et al.  Heterogeneity of the genetic risk in age-related macular disease: a population-based familial risk study. , 2005, Ophthalmology.

[32]  R. Klein,et al.  Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.

[33]  R. Klein,et al.  Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. , 2003, Ophthalmology.

[34]  A Hofman,et al.  Risk factors for age-related macular degeneration: Pooled findings from three continents. , 2001, Ophthalmology.

[35]  George A. Williams,et al.  The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. , 1999, Controlled clinical trials.

[36]  J S Sunness,et al.  The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. , 1999, Molecular vision.

[37]  J S Sunness,et al.  Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. , 1999, Ophthalmology.

[38]  A Hofman,et al.  Genetic risk of age-related maculopathy. Population-based familial aggregation study. , 1998, Archives of ophthalmology.

[39]  H Schatz,et al.  Atrophic macular degeneration. Rate of spread of geographic atrophy and visual loss. , 1989, Ophthalmology.

[40]  J. Vander.  Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration , 2007 .

[41]  D. Weeks,et al.  Susceptibility genes for age-related maculopathy on chromosome 10q26. , 2005, American journal of human genetics.

[42]  R. Klein,et al.  The epidemiology of age-related macular degeneration. , 2004, American journal of ophthalmology.

[43]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[44]  Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. , 2000, Ophthalmology.

[45]  B S Hawkins,et al.  Epidemiology of age-related macular degeneration. , 1999, Molecular vision.

[46]  Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. , 1992, Archives of ophthalmology.